Skip to main content
. 2025 Sep 23;15(10):1497. doi: 10.3390/life15101497
AI activity index
ALCAM activated leukocyte cell adhesion molecule
Anti-dsDNA anti-double-stranded deoxyribonucleic acid
ACR American College of Rheumatology
AUC area under the curve
BAFF B cell activating factor
BILAG British Isles Lupus Assessment Group
BLyS B lymphocyte stimulator
CD163 cluster of differentiation 163
CRR complete renal response
CXCL C-X-C motif ligand
DORIS definitions of remission in SLE
DNA deoxyribonucleic acid
eGFR estimated glomerular filtration rate
ESKD end-stage kidney disease
EULAR European League Against Rheumatism
HR hazard ratio
HMGB1+ high mobility group box 1
IL interleukin
IP-10 interferon-γ inducible protein-10
KDIGO kidney disease improving global outcomes
LN lupus nephritis
MCP-1 monocyte chemoattractant protein-1
miRNAs micro ribonucleic acids
MPs microparticles
NGAL neutrophil gelatinase-associated lipocalin
NK natural killer
NPV negative predictive values
OR odds ratio
PCR protein-creatinine ratio
PERR primary efficacy renal response
PPV positive predictive value
RNA ribonucleic acid
ROC receiver operating characteristic
SLE systemic lupus erythematosus
SLEDAI SLE disease activity index
SLE-ELISpot anti-dsDNA autoantibodies secreting cells enzyme-linked immune sorbent spot
Sn sensitivity
Sp specificity
TWEAK tumor necrosis factor-like weak inducer of apoptosis
VCAM-1 vascular cell adhesion molecule-1